316 related articles for article (PubMed ID: 15162126)
1. Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells.
Boda B; Mas C; Giudicelli C; Nepote V; Guimiot F; Levacher B; Zvara A; Santha M; LeGall I; Simonneau M
Eur J Hum Genet; 2004 Sep; 12(9):729-37. PubMed ID: 15162126
[TBL] [Abstract][Full Text] [Related]
2. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
Wirth B
Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
[TBL] [Abstract][Full Text] [Related]
3. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations.
Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C
Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338
[TBL] [Abstract][Full Text] [Related]
4. [Molecular basis of spinal muscular atrophy: th SMN gene].
Tizzano E; Baiget M
Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
[TBL] [Abstract][Full Text] [Related]
6. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
Kashima T; Manley JL
Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
[TBL] [Abstract][Full Text] [Related]
7. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
Ogino S; Wilson RB
Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
[TBL] [Abstract][Full Text] [Related]
8. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
[TBL] [Abstract][Full Text] [Related]
10. Spinal muscular atrophy: state-of-the-art and therapeutic perspectives.
Wirth B
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):87-95. PubMed ID: 12215230
[TBL] [Abstract][Full Text] [Related]
11. Best practice guidelines for molecular analysis in spinal muscular atrophy.
Scheffer H; Cobben JM; Matthijs G; Wirth B
Eur J Hum Genet; 2001 Jul; 9(7):484-91. PubMed ID: 11464239
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of deletional damage in SMN1, SMN2, and NAIP genes in patients with spinal muscular atrophy in the northwestern region of Russia].
Glotov AS; Kiselev AV; Ivashchenko TE; Baranov VS
Genetika; 2001 Aug; 37(8):1156-9. PubMed ID: 11642117
[TBL] [Abstract][Full Text] [Related]
13. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid increases SMN levels in spinal muscular atrophy patient cells.
Sumner CJ; Huynh TN; Markowitz JA; Perhac JS; Hill B; Coovert DD; Schussler K; Chen X; Jarecki J; Burghes AH; Taylor JP; Fischbeck KH
Ann Neurol; 2003 Nov; 54(5):647-54. PubMed ID: 14595654
[TBL] [Abstract][Full Text] [Related]
15. High incidence of SMN1 gene deletion in Moroccan adult-onset spinal muscular atrophy patients.
Bouhouche A; Benomar A; Birouk N; Bouslam N; Ouazzani R; Yahyaoui M; Chkili T
J Neurol; 2003 Oct; 250(10):1209-13. PubMed ID: 14586604
[TBL] [Abstract][Full Text] [Related]
16. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene.
Cuscó I; Barceló MJ; Baiget M; Tizzano EF
Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269
[TBL] [Abstract][Full Text] [Related]
17. Identification of a candidate modifying gene for spinal muscular atrophy by comparative genomics.
Scharf JM; Endrizzi MG; Wetter A; Huang S; Thompson TG; Zerres K; Dietrich WF; Wirth B; Kunkel LM
Nat Genet; 1998 Sep; 20(1):83-6. PubMed ID: 9731538
[TBL] [Abstract][Full Text] [Related]
18. Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension.
Gérard B; Ginet N; Matthijs G; Evrard P; Baumann C; Da Silva F; Gérard-Blanluet M; Mayer M; Grandchamp B; Elion J
Hum Mutat; 2000 Sep; 16(3):253-63. PubMed ID: 10980532
[TBL] [Abstract][Full Text] [Related]
19. Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy.
Taylor JE; Thomas NH; Lewis CM; Abbs SJ; Rodrigues NR; Davies KE; Mathew CG
Eur J Hum Genet; 1998; 6(5):467-74. PubMed ID: 9801871
[TBL] [Abstract][Full Text] [Related]
20. Determination of SMN1 and SMN2 copy number using TaqMan technology.
Anhuf D; Eggermann T; Rudnik-Schöneborn S; Zerres K
Hum Mutat; 2003 Jul; 22(1):74-8. PubMed ID: 12815596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
